- Details for Erlotinib Hydrochloride
-
Erlotinib Hydrochloride 183319-69-9
| Category : |
Intermediates/Pharmaceutical intermediates |
 |
| CAS NO : |
183319-69-9 |
| EC NO : |
|
| MF : |
C22H24ClN3O4 |
| MW : |
429.8967 |
| Specification : |
99.0% |
| Packing : |
Based on customer needs |
| Product description : |
Please feel free to contact us for our stock position and price.
Call us immediately to get the latest batch of COA and firm offer.
The packaging method depends on the quantity and product property. We also offer a flexible packaging service as per customer’s requirement.
Under normal circumstances, all quotations include domestic freight.
Hereby we highlight some key messages for your information:
1.Quotation: Our quotation is usually valid for 2 to 4 weeks due to the market fluctuation. If you have any inquiry, please contact our sales managers.
2.Quality: We have established the finished products releasing procedure in order to regulate the analysis, examine and releasing management before product distribution, so as to ensure the products quality.
3.Order:Welcome to call and to place the order! Or you can follow us at the below accounts.~~~
Disclaimer:Products are only available to countries where there is no valid patent protection. Products still covered by patents rights are available exclusively for experimental or registration purpose pursuant to national applicable law, and shall be sold in strict accordance with the laws of the People's Republic of China and the laws of the Buyer's country. All products are not for human use. Buyer is obligated for evaluation of the patent situation in its domestic market and shall be held liable for uses which do not fall within the scope of the experimental or registration use exception and are not permitted by national applicable law. |
| Uses : |
Anti-Cancer |
| Synonyms : |
ERLOTINIB HCL SALT;Erlotinib, Hydrochloride Salt;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4- Hydrochloride;quinazolinamine, Hydrochloride Salt, OSI 774, Tarceva;N-(3-Ethynylphenyl)-6,7-bis-(2-methoxyethoxy)-quinazolin-4-amine Hydrochloride;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4yl]-(3-ethynyl-phenyl)-amine;Tarceva Hydrochloride See E625000;Erlotinib HCl;N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride;6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride;Erlotinib, OS-774;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride (1:1);N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide;N-(4-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride (1:1); |
| Molecular Structure : |
 |